• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Cognitive Disorders  • Dementias  • Neurology, Other  • Psychiatry  • Depression  • Alert me on articles by topic  Social Bookmarking   What's this?

Using the AD8, a Brief Informant Interview, as a Self-rating Tool to Detect Dementia

James E. Galvin, MD, MPH; Catherine M. Roe, PhD; Mary A. Coats, RN, MSN; John C. Morris, MD

Arch Neurol. 2007;64(5):725-730.

Objective  To test the ability of patients to rate their own cognitive ability using the AD8 compared with informant and clinician ratings of cognitive status.

Design, Setting, and Patients  The AD8 was administered to 325 consecutive participant-informant dyads enrolled in a longitudinal study at Washington University School of Medicine between April 4, 2005, and December 15, 2005. The number of AD8 items endorsed by the participant was compared with informant answers and an independently derived Clinical Dementia Rating.

Main Outcome Measure  Strength of association was measured with Spearman () and intraclass correlation coefficients. Receiver operator characteristic curves assessed the discriminative properties of the AD8.

Results  The mean age of participants and informants was 72.8 years (range, 43-104 years) and 66.4 years (range, 24-101 years), respectively. The Clinical Dementia Rating was correlated with both informant ( = 0.75, P<.001) and participant ( = 0.34, P<.001) AD8 scores. Participants' AD8 scores had adequate agreement with informants' AD8 scores (intraclass correlation coefficient, 0.53; 95% confidence interval, 0.41-0.62) and correlated with subjective complaints of memory problems ( = 0.47, P<.001) but not with estimates of symptom duration. The area under the receiver operator characteristic curve for the informant AD8 was 0.89 (95% confidence interval, 0.86-0.93); for the participant AD8, it was 0.78 (95% confidence interval, 0.68-0.78).

Conclusions  The AD8 is a brief measure that, when completed by an informant, differentiates nondemented from demented individuals. We now demonstrate that a self-completed AD8 also differentiates nondemented from demented individuals, although the utility was better in mildly impaired individuals compared with more demented individuals. In the absence of a reliable informant, the AD8 may be asked of the participant to gain an understanding of their perception of cognitive status.

Author Affiliations: Departments of Neurology (Drs Galvin and Morris and Ms Coats), Anatomy and Neurobiology (Dr Galvin), and Pathology and Immunology (Dr Morris); Division of Biostatistics (Dr Roe); and the Alzheimer Disease Research Center (Drs Galvin, Roe, and Morris and Ms Coats), Washington University School of Medicine, St Louis, Mo.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The impact of dementia prevalence on the utility of the AD8
Christensen
Brain 2012;135:e203-e203.
FULL TEXT  

Reply: The impact of dementia prevalence on the utility of the AD8
Galvin and Morris
Brain 2012;135:e204-e204.
FULL TEXT  

Application of AD8 Questionnaire to Screen Very Mild Dementia in Taiwanese
Yang et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2011;26:134-138.
ABSTRACT  

Relationship of dementia screening tests with biomarkers of Alzheimer's disease
Galvin et al.
Brain 2010;133:3290-3300.
ABSTRACT | FULL TEXT